52.6
Aptevo Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
27.5
FY23:
19.1
FY24:
10.7
FY25:
23.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
4.03
FY22:
6.77
FY23:
5.78
FY24:
4.93
FY25:
4.11
Total assets
Change from FY21 to FY25
millions USD
FY21:
56.6
FY22:
34.2
FY23:
24.8
FY24:
15.6
FY25:
27.2
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
34.8
FY22:
8.71
FY23:
7.22
FY24:
6.21
FY25:
6.05
(negative)
Change from FY21 to FY25
millions USD
FY21:
20.6
FY22:
7.54
FY23:
5.40
FY24:
4.63
FY25:
3.76
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.22
FY22:
18.0
FY23:
12.2
FY24:
4.76
FY25:
17.4
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
56.6
FY22:
34.2
FY23:
24.8
FY24:
15.6
FY25:
27.2
All amounts in millions USD